Aviva’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-115,719
Closed -$10.3M 755
2017
Q1
$10.3M Sell
115,719
-6,411
-5% -$527K 0.06% 334
2016
Q4
$8.64M Buy
122,130
+6,749
+6% +$503K 0.05% 376
2016
Q3
$9.12M Buy
115,381
+2,324
+2% +$198K 0.06% 368
2016
Q2
$10.3M Buy
113,057
+3,923
+4% +$332K 0.07% 309
2016
Q1
$9.27M Sell
109,134
-52
-0% -$3.87K 0.07% 316
2015
Q4
$8.62M Sell
109,186
-1,621
-1% -$128K 0.07% 324
2015
Q3
$7.8M Sell
110,807
-2,313
-2% -$190K 0.06% 331
2015
Q2
$10.2M Buy
113,120
+4,710
+4% +$454K 0.07% 299
2015
Q1
$10.9M Buy
108,410
+25,072
+30% +$2.53M 0.07% 307
2014
Q4
$8.38M Sell
83,338
-220
-0.3% -$21.9K 0.07% 341
2014
Q3
$8.04M Sell
83,558
-260
-0.3% -$24.6K 0.06% 340
2014
Q2
$7.81M Sell
83,818
-660
-0.8% -$57.7K 0.06% 353
2014
Q1
$7.02M Buy
84,478
+4,040
+5% +$328K 0.06% 361
2013
Q4
$6.74M Buy
80,438
+29,343
+57% +$2.39M 0.06% 361
2013
Q3
$3.79M Buy
51,095
+17,335
+51% +$1.3M 0.03% 504
2013
Q2
$2.67M Buy
+33,760
New +$2.71M 0.03% 529

Other funds holding MJN

Aviva's MJN Position: Q2 2017 in Review

Aviva sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 115,719 shares — an estimated $10.3M sold.

Aviva first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $10.9M in Q1 2015. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Aviva reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Aviva sold 115,719 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $10.3M.
  • Aviva first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Aviva's Mead Johnson Nutrition Company position peaked at $10.9M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Aviva's 13F filing for Q2 2017, filed 7 Aug 2017.